GSK And Takeda Challenge Latest Data Linking TZDs To Cardiovascular Events
This article was originally published in The Pink Sheet Daily
Executive Summary
Retrospective analysis by Canadian institute points to increased risk of congestive heart failure; acute MI appears limited to Avandia.
You may also be interested in...
Avandia Expands Black Box With Heart Attack Risk Information
FDA revises labeling for all oral anti-diabetics to include warning about the absence of conclusive evidence of cardiovascular risk.
Orphan Drug Czar Will Push Legislators For More Grant Funding In 2008
For the past 15 years, funding for the grants program at FDA's Office of Orphan Products Development has remained stagnant at $14 million
Shire Shuffles Corporate Leadership: CFO Russell Rises To CEO
Chairman Cavanaugh retires, to be replaced in June by former chief exec Emmens.